Collplant Biotechnologies Ltd ADR (CLGN)
[[ item.lastPrice ]] [[ item.priceChange ]] ([[ item.percentChange ]]) [[ item.tradeTime ]] [NASDAQ]
[[ item.bidPrice ]] x [[ item.bidSize ]] [[ item.askPrice ]] x [[ item.askSize ]]
[[ session ]] by (Cboe BZX)
[[ item.lastPrice ]] [[ item.priceChange ]] ([[ item.percentChange ]]) [[ item.tradeTime ]] [NASDAQ]
[[ item.bidPrice ]] x [[ item.bidSize ]] [[ item.askPrice ]] x [[ item.askSize ]]
[[ session ]] [[ item.lastPriceExt ]] [[ item.priceChangeExt ]] ([[ item.percentChangeExt ]]) [[ item.tradeTimeExt ]]
Fiscal Year End Date: 12/31
| 03-2018 | 12-2017 | 09-2017 | 06-2017 | 03-2017 | |
| Assets | |||||
| Current Assets | |||||
| Cash & Cash Equivalents | 3,941 | 5,139 | N/A | N/A | N/A |
| Receivables | 264 | 102 | N/A | N/A | N/A |
| Inventories | 295 | 202 | N/A | N/A | N/A |
| Other current assets | 553 | 1,022 | 0 | 0 | 0 |
| TOTAL | $5,053 | $6,465 | $N/A | $N/A | $N/A |
| Non-Current Assets | |||||
| PPE Net | 1,388 | N/A | N/A | N/A | N/A |
| Other Non-Current Assets | 591 | 172 | 0 | 0 | 0 |
| TOTAL | $1,979 | $172 | $N/A | $N/A | $N/A |
| Total Assets | $7,032 | $8,089 | $N/A | $N/A | $N/A |
| Liabilities | |||||
| Current Liabilities | |||||
| Accounts payable and accrued liabilities | 1,650 | 843 | 0 | 0 | 0 |
| Other current liabilities | N/A | 576 | N/A | N/A | N/A |
| TOTAL | $1,650 | $1,419 | $N/A | $N/A | $N/A |
| Non-Current Liabilities | |||||
| Long Term Debt | N/A | 3,663 | N/A | N/A | N/A |
| Other Non-Current Liabilities | 402 | 386 | 0 | 0 | 0 |
| TOTAL | $402 | $4,049 | $N/A | $N/A | $N/A |
| Total Liabilities | $2,052 | $5,468 | $N/A | $N/A | $N/A |
| Shareholders' Equity | |||||
| Common Shares | 1,459 | 1,442 | N/A | N/A | N/A |
| Retained earnings | -51,365 | -50,297 | N/A | N/A | N/A |
| Other shareholders' equity | 3,616 | 0 | 0 | 0 | 0 |
| TOTAL | $4,980 | $2,621 | $N/A | $N/A | $N/A |
| Total Liabilities And Equity | $7,032 | $8,089 | $0 | $0 | $0 |